Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Cash from Investing Activities (2020 - 2025)

Historic Cash from Investing Activities for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$2.9 million.

  • PROCEPT BioRobotics' Cash from Investing Activities fell 106585.37% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.7 million, marking a year-over-year increase of 2736.4%. This contributed to the annual value of -$4.4 million for FY2024, which is 8250.81% up from last year.
  • According to the latest figures from Q3 2025, PROCEPT BioRobotics' Cash from Investing Activities is -$2.9 million, which was down 106585.37% from -$2.8 million recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year Cash from Investing Activities high stood at -$39000.0 for Q1 2021, and its period low was -$8.7 million during Q4 2023.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$1.2 million (2024), whereas its average is -$2.1 million.
  • In the last 5 years, PROCEPT BioRobotics' Cash from Investing Activities tumbled by 960727.27% in 2023 and then skyrocketed by 9574.39% in 2024.
  • PROCEPT BioRobotics' Cash from Investing Activities (Quarter) stood at -$332000.0 in 2021, then crashed by 160.84% to -$866000.0 in 2022, then plummeted by 906.35% to -$8.7 million in 2023, then skyrocketed by 86.53% to -$1.2 million in 2024, then tumbled by 144.29% to -$2.9 million in 2025.
  • Its Cash from Investing Activities was -$2.9 million in Q3 2025, compared to -$2.8 million in Q2 2025 and -$1.8 million in Q1 2025.